Preoperative Chemotherapy and Radiation for Borderline Resectable Pancreatic Cancer
Release Date:
Interview with Matthew H. G. Katz, MD, author of Preoperative Modified FOLFIRINOX Treatment Followed by Capecitabine-Based Chemoradiation for Borderline Resectable Pancreatic Cancer: Alliance for Clinical Trials in Oncology Trial A021101
Preoperative Chemotherapy and Radiation for Borderline Resectable Pancreatic Cancer